REFERENCE
1. Nicholson T, Duncan DF, White JB. Is recreational drug use normal? J Subst Use. 2002 Jan 1;7(3):116–23.
2. SHANNON M. Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pediatr Emerg Care. 2000;16(5).
3. Walubo A, Seger D. Fatal multi-organ failure after suicidal overdose with MDMA, “Ecstasy”: Case report and review of the literature. Hum Exp Toxicol. 1999;18(2):119–25.
4. Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr. 2004;16(2):206–10.
5. Eede H Vanden, Montenij LJ, Touw DJ, Norris EM. Rhabdomyolysis in MDMA intoxication: A rapid and underestimated killer. “clean” Ecstasy, a safe party drug? Journal of Emergency Medicine. 2012;42(6):655–8.
6. Cunningham M. Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure. Intensive Crit Care Nurs. 1997;13(4):216–23.
7. Halachanova V. Delayed rhabdomyolysis after ecstasy use [3]. Mayo Clin Proc. 2001;76(1):112–3.
8. Bedry R, Baudrimont I, Deffieux G, Creppy EE, Pomies JP, Ragnaud JM, et al. Wild-Mushroom Intoxication as a Cause of Rhabdomyolysis. New England Journal of Medicine. 2001 Sep 13;345(11):798–802.
9. Benjamin A, Anderson A, Zrelec S. Delayed rhabdomyolysis secondary to anabolic-androgenic steroid use. Clin Med (Lond). 2020 Nov;20(6):e260–1.
10. Russell T, Riazi S, Kraeva N, Steel AC, Hawryluck LA. Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia. 2012;67(9):1021–4.
11. Lehmann ED, Thom CH, Croft DN. Delayed severe rhabdomyolysis after taking “ecstasy”. Vol. 71, Postgraduate medical journal. England; 1995. p. 186–7.
12. Luckoor P, Salehi M, Kunadu A. Exceptionally high creatine kinase (CK) levels in multicausal and complicated rhabdomyolysis: A case report. American Journal of Case Reports. 2017;18:746–9.
13. Ramcharan S, Meenhorst PL, Otten JMMB, Koks CHW, De Boer D, Maes RAA, et al. Survival after massive ecstasy overdose. J Toxicol Clin Toxicol. 1998;36(7):727–31.
14. Hall AP, Henry JA. Acute toxic effects of ‘ Ecstasy ’ ( MDMA ) and related compounds : overview of pathophysiology and clinical management. Br J Anaesth. 2006;96(6):678–85.
15. Bora F, Yılmaz F, Bora T. Ecstasy ( MDMA ) and its effects on kidneys and their treatment : a review Ecstasy ( Unit ).
16. Ricaurte GA, Mccann UD. doi:10.1016/S0140-6736(05)66737-2. 2005;1–9.
17. Frank A. Mangano, Mark Zaontz JJP. Computed tomography of Acute Renal Failure Secondary to Rhbdomyolysis. 1985. p. 777–9.
18. Nakahara K, Tanaka H, Masutani K, Yanagida T, Kashiwagi M, Mizumasa T, et al. The value of computed tomography and magnetic resonance imaging to diagnose rhabdomyolysis in acute renal failure. Nephrology Dialysis Transplantation. 1999;14(6):1564–7.
19. Moratalla MB, Braun P, Fornas GM. Importance of MRI in the diagnosis and treatment of rhabdomyolysis. Eur J Radiol. 2008;65(2):311–5.
20. Candela N, Silva S, Georges B, Cartery C, Robert T, Moussi-Frances J, et al. Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients. Ann Intensive Care. 2020;10(1):1–7.
21. Akkina SK, Ricardo AC, Patel A, Das A, Bazzano LA, Brecklin C, et al. Illicit drug use, hypertension, and chronic kidney disease in the US adult  population. Transl Res. 2012 Dec;160(6):391–8.
22. Vupputuri S, Batuman V, Muntner P, Bazzano LA, Lefante JJ, Whelton PK, et al. The risk for mild kidney function decline associated with illicit drug use among  hypertensive men. Am J Kidney Dis. 2004 Apr;43(4):629–35.